Finished
Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NCT05181306 · Southwest Hospital, China · Updated 6 Jan 2022
- What is being tested
- Robotic-assisted Total Gastrectomy with D2 Lymphadenectomy; Laparoscopic-assisted Total Gastrectomy with D2 Lymphadenectomy
- For
- Gastric Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 430 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Oct 2010, ends 30 July 2016. Registered 6 Jan 2022.
- Results
- None posted yet.
In the researchers' words
This study is a retrospective, single-center, controlled and observation trial comparing robotic total gastrectomy with D2 lymph nodal dissection for locally advanced gastric cancer patients with laparoscopic procedure.
Sites
- SiteChongqing, Chongqing Municipality, China